Small study in China finds coronavirus living in semen of some men

Coronavirus found in semen of young men with COVID-19

Coronavirus found in semen of young men with COVID-19

"It suggests that obtaining answers to such questions should be an additional priority considering our global need to understand the dynamics of person-to-person transmission of Covid-19".

The Chinese Biotech company Sinovac is already ahead in the race of producing the vaccine against COVID-19.

Until recently, coronaviral drug discovery had been a low priority relative to efforts to fight other viral diseases such as influenza, despite the fact that previous coronaviruses were responsible for recent epidemics such as severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). And it is claiming a Phase-3 trial from World Health Organization to launch the trial in the regions of China where coronavirus still spreading rapidly. This company is developing a vaccine on a novel approach by using specially designed m-RNA. The produced antigen helps to awake the immune system and work against Coronavirus.

The findings have left scientists anxious that the deadly disease could be sexually transmitted, raising the prospect of health chiefs advising people to avoid having sex for a set time after the end of their symptoms. The Jenner Institute and Oxford Vaccine Group developed the vaccine at the University Of Oxford. There is a risk that SARS-CoV-2 in some way into the organs of the urogenital system. This result marked an initial success in the testing process. Following the results, it will enter into the clinical test of Phase II and Phase - III shortly. Older mice made more of the two proteins in nasal cells than younger mice. However, it is said that the vaccine might be costly as it is completely governed by the government of US by giving the company $483 million through the Biomedical Advanced Research and Development Authority (BARDA).

Interpol issues red notice for diplomat's wife Anne Sacoolas over United Kingdom death
While admitting to driving on the other side of the road, Sacoolas claimed diplomatic immunity after the crash outside the U.S. Air Force listening station at RAF Croughton and returned to the U.S. on September 15, sparking an global outcry.

Pfizer, with the help of the German pharma company BioNTech, is developing BNT162 vaccine.

The vaccine is under trials, and everything goes well it will be out in the market by October this year.

The vaccine consists of a weakened version of Chimpanzee's Adenovirus as a vector.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.